As of Feb 12
| -0.015 / -7.50%|
The 1 analysts offering 12-month price forecasts for Amarantus Bioscience Holdings Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +4,764.86% increase from the last price of 0.19.
The current consensus among 1 polled investment analysts is to Buy stock in Amarantus Bioscience Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.